FDA’s Rejection of a Major Vaping Brand Shows It Is Arbitrarily Applying a Nebulous Legal Standard


The agency’s obsession with adolescent vaping is driving decisions that undermine public health.

The Food and Drug Administration (FDA) recently issued “marketing denial orders” (MDOs) for the myblu vaping device and several of its tobacco-flavored proprietary pods.

The decision, which the FDA announced last Friday, affects one of the leading e-cigarette brands and does not bode well for smokers who have switched to vaping or might be interested in doing so.

The FDA concluded that allowing the sale of the myblu products would not be “appropriate for the protection of the public health,” which illustrates how nebulous that standard is and how arbitrarily the FDA applies it.

Read full article here.

Jacob Sullum – Reason – 2022-04-13

Want More Investigative Content?

Curate RegWatch
Curate RegWatchhttps://regulatorwatch.com
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.


Please enter your comment!
Please enter your name here


All In (Part 2) | Is Big Tobacco A Threat to...

Is big tobacco a threat to the nicotine vaping industry? This is an old and touchy question for many vaping advocates. Most assume that at some...

Vaping Coverage Get it NOW!

Sign Up for Incisive Content!

RegWatch original video is designed to move opinion. Get our videos first and be the first to share.

Your Information will never be shared with any third party